Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.8T | 7.7T | 7.1T | 5.6T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 508.7B | 410.0B | 814.6B | 779.4B |
Other operating expenses | 6.3B | 71.6B | -87.8B | -118.3B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 481.5B | 482.6B | 583.6B | 601.0B |
Other income expense | 329.9B | 583.0B | 261.6B | 319.2B |
Pretax income | 428.3B | 426.8B | 305.2B | 254.6B |
Tax provision | 10.3B | 152.0B | 23.5B | 26.8B |
Net income | 418.0B | 274.8B | 281.7B | 227.8B |
Basic EPS | 68 | — | — | — |
Diluted EPS | 68 | — | — | — |
Basic average shares | 6.4B | — | — | — |
Diluted average shares | 6.4B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | 17.3B | -15.0B | -22.9B | -18.8B |
Preferred stock dividends | — | — | — | — |